Covaxin Proven Safe for Children of 2-18 Years Age Group in Phase III Study: Bharat Biotech

"The study has been accepted and published in Lancet Infectious diseases, peer-reviewed high impact factor journal," the company said.

from Top India News- News18.com https://ift.tt/0AwWVtm